147 related articles for article (PubMed ID: 10697532)
21. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia.
Pathansali R; Smith N; Bath P
Platelets; 2001 Aug; 12(5):292-7. PubMed ID: 11487381
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of chronic immune thrombocytopenic purpura.
Cines DB; McMillan R
Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
[TBL] [Abstract][Full Text] [Related]
23. [Expression patterns of platelet membrane glycoprotein in healthy adults].
Huang F; Liu R; Liu L
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):465-7. PubMed ID: 11721409
[TBL] [Abstract][Full Text] [Related]
24. Measurements of in vivo megakaryocytopoiesis: studies in nonhuman primates and patients.
Tomer A; Harker LA
Stem Cells; 1996; 14 Suppl 1():18-30. PubMed ID: 11012199
[TBL] [Abstract][Full Text] [Related]
25. Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes.
Duperray A; Berthier R; Chagnon E; Ryckewaert JJ; Ginsberg M; Plow E; Marguerie G
J Cell Biol; 1987 Jun; 104(6):1665-73. PubMed ID: 3108266
[TBL] [Abstract][Full Text] [Related]
26. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.
Phillips DR; Nannizzi-Alaimo L; Prasad KS
Thromb Haemost; 2001 Jul; 86(1):246-58. PubMed ID: 11487013
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
28. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC
Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022
[TBL] [Abstract][Full Text] [Related]
29. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
30. Expression of cox-2, tie-2 and glycodelin by megakaryocytes in patients with chronic myeloid leukaemia and polycythaemia vera.
Zetterberg E; Lundberg LG; Palmblad J
Br J Haematol; 2003 May; 121(3):497-9. PubMed ID: 12716375
[TBL] [Abstract][Full Text] [Related]
31. Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(4B):3229-35. PubMed ID: 10652616
[TBL] [Abstract][Full Text] [Related]
32. Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura.
Zent CS; Ratajczak J; Ratajczak MZ; Anastasi J; Hoffman PC; Gewirtz AM
Br J Haematol; 1999 May; 105(2):452-8. PubMed ID: 10233421
[TBL] [Abstract][Full Text] [Related]
33. Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells.
Chang CL; Hora N; Huberman N; Hinderer R; Kukuruga M; Hanash SM
Proteomics; 2001 Nov; 1(11):1415-23. PubMed ID: 11922601
[TBL] [Abstract][Full Text] [Related]
34. Analysis of human megakaryocytic cells using dual-color immunofluorescence labeling.
Law HK; Bol SJ; Palatsides M; Williams NT
Cytometry; 2000 Dec; 41(4):308-15. PubMed ID: 11084616
[TBL] [Abstract][Full Text] [Related]
35. Augmentation of the number of nucleolar organizer regions in human megakaryocyte cell lines after induction of polyploidization by a microtubule inhibitor.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Eur J Clin Invest; 1998 Feb; 28(2):138-44. PubMed ID: 9541128
[TBL] [Abstract][Full Text] [Related]
36. Low megakaryocyte ploidy in Ph-positive chronic myelogenous leukemia measured by flow cytometry.
Jacobsson S; Wadenvik H; Kutti J; Swolin B
Am J Clin Pathol; 1999 Feb; 111(2):185-90. PubMed ID: 9930139
[TBL] [Abstract][Full Text] [Related]
37. Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes.
Tomer A
Blood; 2004 Nov; 104(9):2722-7. PubMed ID: 15198950
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of CD9 expression during TPA treatment of K562 cells.
Le Naour F; Francastel C; Prenant M; Lantz O; Boucheix C; Rubinstein E
Leukemia; 1997 Aug; 11(8):1290-7. PubMed ID: 9264383
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.
Vannucchi AM; Pancrazzi A; Guglielmelli P; Di Lollo S; Bogani C; Baroni G; Bianchi L; Migliaccio AR; Bosi A; Paoletti F
Am J Pathol; 2005 Sep; 167(3):849-58. PubMed ID: 16127162
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of thrombospondin and glycoprotein IIb-IIIa by a purified megakaryocyte human bone marrow culture.
Sitar G; Borroni R; Pesce G
Haematologica; 1986; 71(5):389-93. PubMed ID: 3096834
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
